Skip to main content
main-content

Keep up with the latest developments in diabetes

News, expert interviews, & educational resources

FEATURED NEWS

04-09-2021 | Pathophysiology | News

Ethnicity may be independently linked to beta-cell function

Black West African men have lower levels of insulin secretion in response to a meal than their White Northern European counterparts, irrespective of insulin sensitivity, study findings indicate.

MOST READ | SGLT2 inhibitors

04-13-2021 | Dapagliflozin | News

DAPA-HF: Consistent benefits of dapagliflozin in men and women

Adding dapagliflozin to standard care improves outcomes for people with heart failure and reduced ejection fraction irrespective of sex, suggests a prespecified subgroup analysis of the DAPA-HF trial.

SGLT2 inhibitor use in type 2 diabetes management

Learn about prescribing these medications with guidance from the Improving Diabetes Steering Committee.

  • » A prescribing tool to inform prescribing decisions for SGLT2 inhibitors
  • » SGLT2 inhibitors: Key evidence and implications for clinical practice
  • » Translating SGLT2 inhibitor cardiovascular evidence into practice
  • » This content is intended only for UK healthcare providers and was made possible by educational funding provided by Napp Pharmaceuticals Ltd.

MOST READ | Diabetes devices & technology

04-07-2021 | Flash glucose monitoring | News

Real-world data support benefits of flash glucose monitoring

Flash glucose monitoring is associated with small but sustained improvements in glycemic control and a reduction in severe hypoglycemia relative to self-monitoring of blood glucose in type 1 diabetes, observational data show.

Flash glucose monitoring technology

Browse new slide sets summarizing the latest results from real-world studies.

MOST READ | Cardiovascular disorders

04-08-2021 | Stroke | News

Genetic analysis backs causal link between blood glucose and stroke

A Mendelian analysis supports a causal effect of hyperglycemia on stroke risk, and the researchers also pinpoint the medications most likely to reduce this risk.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

MOST LISTENED | GLP-1 receptor agonists

03-23-2021 | Semaglutide | Commentary | Article

STEP 4: Long-term semaglutide treatment combats weight regain

Domenica Rubino discusses the chronicity of obesity, and how STEP 4 demonstrates the need for long-term semaglutide treatment to avoid weight regain (5:59).

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

Podcasts

Interviews with experts on diabetes patient care

Image Credits